[go: up one dir, main page]

DE60030859D1 - Gruppen von borrelia burgdorferi, die lyme krankheit verursachen - Google Patents

Gruppen von borrelia burgdorferi, die lyme krankheit verursachen

Info

Publication number
DE60030859D1
DE60030859D1 DE60030859T DE60030859T DE60030859D1 DE 60030859 D1 DE60030859 D1 DE 60030859D1 DE 60030859 T DE60030859 T DE 60030859T DE 60030859 T DE60030859 T DE 60030859T DE 60030859 D1 DE60030859 D1 DE 60030859D1
Authority
DE
Germany
Prior art keywords
lyme disease
creating
groups
ospc
borrelia burgdorferi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60030859T
Other languages
English (en)
Other versions
DE60030859T2 (de
Inventor
J Dattwyler
Gerald Seinost
Daniel Dykhuizen
J Luft
Maria Gomes-Solecki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brook Biotechnologies Inc
Research Foundation of the State University of New York
Original Assignee
Brook Biotechnologies Inc
Research Foundation of the State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brook Biotechnologies Inc, Research Foundation of the State University of New York filed Critical Brook Biotechnologies Inc
Application granted granted Critical
Publication of DE60030859D1 publication Critical patent/DE60030859D1/de
Publication of DE60030859T2 publication Critical patent/DE60030859T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
DE60030859T 1999-06-18 2000-06-19 Gruppen von borrelia burgdorferi, die lyme krankheit verursachen Expired - Lifetime DE60030859T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14004299P 1999-06-18 1999-06-18
US140042P 1999-06-18
PCT/US2000/016915 WO2000078966A1 (en) 1999-06-18 2000-06-19 Groups of borrelia burgdorferi and borrelia afzelii that cause lyme disease in humans

Publications (2)

Publication Number Publication Date
DE60030859D1 true DE60030859D1 (de) 2006-11-02
DE60030859T2 DE60030859T2 (de) 2007-06-14

Family

ID=22489483

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60030859T Expired - Lifetime DE60030859T2 (de) 1999-06-18 2000-06-19 Gruppen von borrelia burgdorferi, die lyme krankheit verursachen

Country Status (9)

Country Link
US (2) US7060281B1 (de)
EP (2) EP1683867B1 (de)
AT (1) ATE340262T1 (de)
AU (1) AU5751000A (de)
DE (1) DE60030859T2 (de)
DK (1) DK1194559T3 (de)
ES (1) ES2272296T3 (de)
PT (1) PT1194559E (de)
WO (1) WO2000078966A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1194559T3 (da) * 1999-06-18 2007-02-05 Univ New York State Res Found Grupper af Borrelia burgdorferi, som forårsager Lyme sygdom hos mennesker
EP1939294A1 (de) 2000-08-18 2008-07-02 Research Foundation Of State University Of New York Rekombinante Konstrukte von Borrelia Burgdorferi
GB2414667A (en) * 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
US8821893B2 (en) * 2004-07-02 2014-09-02 Bio Peptides, Corp. Oral vaccine for Borrelia
EP1957520A4 (de) * 2005-11-29 2009-05-27 Univ Virginia Commonwealth Polyvalentes chimärisches ospc-vaccinogen und diagnostisches antigen
KR102428294B1 (ko) 2006-01-19 2022-08-01 마리 케이 인코포레이티드 카카두 플럼 추출물 또는 아카이 베리 추출물을 포함하는 조성물
WO2008116468A2 (en) 2007-03-26 2008-10-02 Dako Denmark A/S Mhc peptide complexes and uses thereof in infectious diseases
WO2009003493A2 (en) 2007-07-03 2009-01-08 Dako Denmark A/S Mhc multimers, methods for their generation, labeling and use
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
JP2011518338A (ja) 2008-04-22 2011-06-23 リサーチ ファンデーション オブ ステート ユニバーシティ オブ ニューヨーク ボレリア・ブルグドルフェリ（ｂｏｒｒｅｌｉａｂｕｒｇｄｏｒｆｅｒｉ）の細胞エンベロープタンパク質のアレイ
WO2010009735A2 (en) 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
WO2010037402A1 (en) 2008-10-02 2010-04-08 Dako Denmark A/S Molecular vaccines for infectious disease
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
WO2010132758A2 (en) * 2009-05-14 2010-11-18 Gomes-Solecki Maria J Ospc-based diagnostic test for lyme disease
FR2949472B1 (fr) * 2009-08-28 2013-08-09 Biomerieux Sa Proteines utilisees pour le diagnostic d'une borreliose de lyme
EA023290B1 (ru) 2009-08-28 2016-05-31 Мэри Кей Инк. Косметический способ и топическая композиция для омоложения, регенерации и упрочнения кожи во время сна
US20160097768A1 (en) 2010-10-20 2016-04-07 Virginia Commonwealth University Polyvalent chimeric ospc vaccinogen and diagnostic antigen
CN103339151A (zh) * 2010-10-20 2013-10-02 弗吉尼亚联邦大学 多价嵌合OspC疫苗原和诊断抗原
WO2013067448A2 (en) 2011-11-03 2013-05-10 Vca Antech Inc. Compositions and methods to detect various infectious organisms
EP2809348B1 (de) * 2012-02-01 2018-11-07 Biopeptides Corporation Diagnostische peptide für lyme-borreliose
US9562079B2 (en) 2012-04-18 2017-02-07 Zoetis Services Llc Vaccines and methods to treat lyme disease in dogs
RU2514230C1 (ru) * 2012-12-14 2014-04-27 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт биохимии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИ биохимии" СО РАМН) Рекомбинантные химерные полипептиды, несущие эпитопы различных иммунодоминантных белков спирохет комплекса borrelia burgdorferi sensu lato, и способ серодиагностики иксодового клещевого боррелиоза
CA2963643A1 (en) 2014-10-07 2016-04-14 The Research Foundation For The State University Of New York Recombinant borrelia proteins and methods of use thereof
US11209431B2 (en) 2015-10-06 2021-12-28 Bio-Rad Laboratories, Inc. Borrelia immunoassays and materials therefor
WO2025015042A1 (en) 2023-07-10 2025-01-16 Dynavax Technologies Corporation Lyme disease vaccines comprising an adjuvant and a borrelia outer surface protein a antigen
WO2025015077A1 (en) 2023-07-10 2025-01-16 Dynavax Technologies Corporation Lyme disease vaccines comprising an adjuvant and borrelia outer surface protein a and c antigens

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646016A (en) * 1991-02-06 1997-07-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
US6221363B1 (en) 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
EP0686265A4 (de) 1993-02-26 2001-08-22 Cambridge Biotech Corp Verfahren zum induzieren von immunität gegen die lyme-krankheit und ein kolorimetrischer test auf borreliazide aktivität von antisera
AU683260B2 (en) 1993-04-29 1997-11-06 Immuno Aktiengesellschaft Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens
CA2175567C (en) * 1993-11-01 2010-08-10 John J. Dunn Chimeric proteins comprising borrelia polypeptides: uses therefor
AU2207195A (en) * 1994-04-05 1995-10-23 Board Of Regents, The University Of Texas System Modified receptors that continuously signal
AR003941A1 (es) * 1995-04-19 1998-09-30 Polymun Scient Immunbilogische Forschung Gmbh Anticuerpos monoclonales humanos neutralizadores de hiv-1
US5804427A (en) * 1995-05-19 1998-09-08 University Of Massachusetts Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
US5683903A (en) * 1995-05-30 1997-11-04 Smithkline Beecham Corporation Attachment enhanced 293 cells
US6251405B1 (en) 1995-06-07 2001-06-26 Connaught Laboratories, Inc. Immunological combination compositions and methods
US5849891A (en) * 1995-07-28 1998-12-15 National Science Council Satellite RNA from bamboo mosaic virus as a vector for foreign gene expression in plants
GB9517585D0 (en) * 1995-08-29 1995-11-01 Cookson William O C Atopy diagnosis and therapy
US5756294A (en) * 1995-09-25 1998-05-26 Oncormed, Inc. Susceptibility mutation for breast and ovarian cancer
GB9526218D0 (en) * 1995-12-21 1996-02-21 Gene Shears Pty Ltd DNA Sequences
US6255464B1 (en) * 1996-04-18 2001-07-03 The Johns Hopkins University Mad-related genes in the human
DK0896583T3 (da) 1996-05-02 2003-05-26 Dako As Anvendelse af peptidfragmenter fra OspC til diagnostiske metoder
US6110703A (en) * 1996-07-05 2000-08-29 Novo Nordisk A/S Method for the production of polypeptides
US5824318A (en) * 1996-07-24 1998-10-20 American Cyanamid Company Avirulent herpetic viruses useful as tumoricidal agents and vaccines
JP4108755B2 (ja) * 1996-09-11 2008-06-25 大日本住友製薬株式会社 新規セマフォリン遺伝子：セマフォリンｙ
US6131578A (en) * 1996-10-02 2000-10-17 King; George L. Inhibitors of UDP-G1cNAc:Ga1β1-3Ga1NAcαR β1-6 N-acetylglucosaminyltransferase (core 2 G1cNAc-T) and use of the inhibitors to prevent or treat cardiomyopathy associated with diabetes
CA2283193A1 (en) 1997-03-11 1998-09-17 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US6420108B2 (en) * 1998-02-09 2002-07-16 Affymetrix, Inc. Computer-aided display for comparative gene expression
DE19740735A1 (de) 1997-09-16 1999-03-18 Max Planck Gesellschaft Arzneimittel zur Therapie einer manifesten Lyme-Borreliose
US6194556B1 (en) * 1997-12-11 2001-02-27 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therfor
US6150081A (en) * 1997-12-24 2000-11-21 Fuji Photo Film B.V. Silver halide emulsions with recombinant collagen suitable for photographic application and also the preparation thereof
AU762378B2 (en) * 1998-02-17 2003-06-26 Bristol-Myers Squibb Company Members of the D52 gene family
BR9909280A (pt) * 1998-04-01 2000-11-21 Danisco Exoamilases não maltogênicas e sua utilização no retardo de retrogradação de amido
US6245525B1 (en) * 1998-07-27 2001-06-12 Ludwig Institute For Cancer Research Tumor associated nucleic acids and uses therefor
US6248937B1 (en) * 1998-04-27 2001-06-19 The Regents Of The University Of California Transcription factor and method for regulation of seed development, quality and stress-tolerance
JP3631960B2 (ja) 1998-07-31 2005-03-23 ガンダーセン ルテラン メディカル ファウンデイション インコーポレイテッド ワクチンとしてのボレリアブルグドルフェリ外部表面タンパク質ｃ（ｏｓｐｃ）のボレリアシダルエピトープの使用
US6627193B1 (en) * 1999-01-13 2003-09-30 University Of Georgia Research Foundation, Inc. Methods and compositions for control of blood coagulation
US6468773B1 (en) * 1999-05-19 2002-10-22 Genencor International, Inc. Mutant 1,3-propandiol dehydrogenase
DK1194559T3 (da) * 1999-06-18 2007-02-05 Univ New York State Res Found Grupper af Borrelia burgdorferi, som forårsager Lyme sygdom hos mennesker
AU6611900A (en) * 1999-07-30 2001-03-13 Agy Therapeutics, Inc. Techniques for facilitating identification of candidate genes
US6472154B1 (en) * 1999-12-31 2002-10-29 Board Of Regents, The University Of Texas System Polymorphic repeats in human genes
US6337208B1 (en) * 2000-01-03 2002-01-08 Stefan Graupner Cloning vector

Also Published As

Publication number Publication date
US20090060932A2 (en) 2009-03-05
DK1194559T3 (da) 2007-02-05
US20060182756A1 (en) 2006-08-17
DE60030859T2 (de) 2007-06-14
AU5751000A (en) 2001-01-09
ATE340262T1 (de) 2006-10-15
EP1194559B1 (de) 2006-09-20
WO2000078966A1 (en) 2000-12-28
EP1194559A1 (de) 2002-04-10
US7582304B2 (en) 2009-09-01
EP1683867A1 (de) 2006-07-26
PT1194559E (pt) 2007-01-31
ES2272296T3 (es) 2007-05-01
EP1683867B1 (de) 2014-04-09
US7060281B1 (en) 2006-06-13

Similar Documents

Publication Publication Date Title
DE60030859D1 (de) Gruppen von borrelia burgdorferi, die lyme krankheit verursachen
ATE293925T1 (de) Knochendistraktionsvorrichtung
DE60040012D1 (de) Rekombinantes gelatin in impstoffen
MXPA04003333A (es) Remodelado y glicoconjugacion de peptidos.
ATE345133T1 (de) Laktose-freie, nicht-hygroskopische und wasserfreie pharmazeutische zusammensetzungen von descarboethoxyloratadin
DK0598816T3 (da) Osp A-proteiner fra Borrelia Burgdorferi-undergrupper, hvilke proteiner koder for gener og vacciner
DE69032679D1 (de) Threo (2R, 3S)-3-amino-2-hydroxypentansäure und threo (2R,3S)-3-(p-methoxy-benzyloxycarbonyl/FMOC) amino-2-hydroxy-pentansäure
DE69022115D1 (de) Hämostatische, chirurgische Clips.
DE69801369D1 (de) Peptidanaloge des lh-rh, ihre verwendungen und die sie enthaltenden pharmazeutischen zusammensetzungen
DE60000992D1 (de) Desinfizierende zusammensetzung auf basis von h2o2, säuren und metallionen
RS54275B1 (sr) Vodeni 2,6-diizopropilfenol farmaceutski sastavi
DE50013608D1 (de) PIEZOELEKTRISCHER ANTRIEB, sowie System mit piezoelektrischem Antrieb und Schaltungsanordnung
ATE381575T1 (de) Veränderte borrelia burgdorferi ospa
DE69711649D1 (de) P1, p4-dithio-p2,p3-monochloromethylen 5',5'''-diadenosin-p1,p4-tetraphosphat verwendet als anti-thrombose mittel
ATE142888T1 (de) Antigen-wirkende proteine von borrelia burgdorferi
NO20073914L (no) Biologisk aktive peptider
HK1046648B (zh) 包括最少兩個不同變應原蛋白的含雜種多肽疫苗
ATE291080T1 (de) Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden
DE68924601D1 (de) Reinigung von q-beta-replicase.
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
IT1241396B (it) Composizioni tensioattive, loro preparazione e loro impiego come agenti antischiuma. (caso 150-5294)
EP1865062A3 (de) Verändertes OspA der Borrelia burgdorferi
DE68915561D1 (de) Polymerisierbare Zusammensetzung und Polymer, hergestellt aus dieser.
BR9201408A (pt) Composto de dna,sequencia de dna,composto polipeptidico e composicao farmaceutica
IT1293749B1 (it) Ansa bipolare per polipectomia endoscopica

Legal Events

Date Code Title Description
8364 No opposition during term of opposition